Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of immunomodulatory drugs. It plays a critical role in the development of agents that target protein degradation pathways, particularly through modulation of E3 ubiquitin ligases. Its structure enables selective binding to cellular targets involved in inflammation and cancer progression, making it valuable in oncology and autoimmune disease research. It is also explored for its potential in targeted protein degradation therapies, including PROTACs and molecular glues.